Submit to Nutrients Review for Nutrients Propose a Special Issue

Journal Menu

Journal Browser

► Journal Browser

Leptin

Special Issue Editors
Special Issue Information
Keywords
Benefits of Publishing in a Special Issue
Published Papers

A special issue of Nutrients (ISSN 2072-6643).

Deadline for manuscript submissions: closed (20 July 2019) | Viewed by 90012

Share This Special Issue

Special Issue Editors

Prof. Dr. Carlos Diéguez González

E-Mail Website
Guest Editor

Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS), Universidad de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), 15782 Santiago de Compostela, Spain
Interests: endocrinology; growth hormone; leptin; ghrelin; energy metabolism

Prof. Dr. Gema Frühbeck

E-Mail
Co-Guest Editor

Clin Univ Navarra, Metab Res Lab, Avda Pio 12,36, Pamplona 31008, Spain

Special Issue Information

Dear Colleagues,

From an historical point of view there little doubt that the main scienfic development in the field of obesity was the identification of leptin 25 years ago by J. Friedmann. Among many other things, this discovery allowed : a) the recognition of adipose tissue as the secretory organ, with leptin as one of the main adipokines; b) the understanding of the mechanisms governing the energy balance, with particular emphasis in the actions it exerts at the CNS; c) Newer effects exerted at the central level, including metabolic homeostasis, temperature or reward-related mechanisms; d) understanding the adaptations undertaken by many different endocrine systems (thyroid, gonadal, adrenal) in relation to the energy balance; e) the uncovering of some unexpected roles in the regulation of immune function and inflammatory processes; f) the definition of the diagnosis and genetic basis of some subtypes of human obesity (mutations in the leptin and the leptin receptor gene); and g) the treatment of patients with leptin deficiency, including patients with lipodystrophy.

In this Special Issue we welcome contributions related to any aspect of leptin, from mechanistic issues related to the leptin system, to its biological effects. We aim to provide readers with a clear view of the physiological relevance, the role of leptin in disease states including preclinical models, its diagnostic potential, and the therapeutic implications of the leptin system.

Prof. Carlos Diéguez González
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

Leptin and leptin receptor gene expression.
The leptin system and energy balance
The leptin system and metabolic homeostasis.
Leptin and reward
Diet, leptin and neuronal function including neurodegeneration.
Leptin and temperature.
Leptin and neuroendocrine control of pituitary function (gonadal, adrenal, thyroid, GH).
Leptin and cardiovascular function.
Leptin, inflammation and the immune system
Food deprivation, malnutrition.
Leptin in disease states.
Leptin-based therapies.

Benefits of Publishing in a Special Issue

Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (10 papers)

Download All Papers

Order results

Result details

Show export options Show export options

Select all

Export citation of selected articles as:

Research

Jump to: Review

12 pages, 462 KiB

Open AccessArticle

Relationships of Trait Anxiety and Loss of Control Eating with Serum Leptin Concentrations among Youth

by Meghan E. Byrne, Marian Tanofsky-Kraff, Manuela Jaramillo, Lisa M. Shank, Sarah LeMay-Russell, Sarah G. Rubin, Sophie Ramirez, Deborah R. Altman, Natasha A. Schvey, Sheila M. Brady, Lauren B. Shomaker, Amber B. Courville, Shanna B. Yang, Merel Kozlosky, Miranda M. Broadney, Susan Z. Yanovski and Jack A. Yanovski

Nutrients 2019, 11(9), 2198; https://doi.org/10.3390/nu11092198 - 12 Sep 2019

Cited by 12 | Viewed by 4216

Abstract

Loss of control (LOC) eating in youth is associated with elevated fasting serum leptin, even after accounting for adiposity. Anxiety is closely linked to, and may exacerbate, LOC eating. Yet, it remains unclear how anxiety relates to leptin, or if the relationship is moderated by the presence of LOC eating. We examined whether self-reported trait anxiety interacted with LOC eating in relation to leptin in a convenience sample of youths (n = 592; 13.1 ± 2.7 years; body mass index z-score (BMIz) = 0.9 ± 1.1; 61.8% girls; 53.5% non-Hispanic White; 36.6% with LOC eating). LOC eating was assessed by interview. Leptin was measured after an overnight fast. Exploratory analyses were conducted to examine anxiety and LOC eating in relation to laboratory intake patterns in three sub-samples. In a generalized linear model adjusting for relevant covariates, anxiety significantly interacted with LOC eating in relation to leptin (p = 0.02), such that greater trait anxiety related to higher concentrations of leptin only among youth with LOC eating. Trait anxiety was not significantly related to fasting serum leptin independently in a generalized linear model adjusting for age, race, height, sex, study type, and fat mass (kg). Exploratory mechanistic analyses of food intake patterns did not identify consistent results for participants with both anxiety and LOC eating. Among youth with LOC eating, anxiety may be associated with higher serum leptin. Prospective data are required to elucidate the directionality and mechanisms of these relationships. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

13 pages, 1148 KiB

Open AccessArticle

Hypothalamic–Pituitary and Adipose Tissue Responses to the Effect of Resistin in Sheep: The Integration of Leptin and Resistin Signaling Involving a Suppressor of Cytokine Signaling 3 and the Long Form of the Leptin Receptor

by Dorota Anna Zieba, Weronika Biernat, Malgorzata Szczesna, Katarzyna Kirsz and Tomasz Misztal

Nutrients 2019, 11(9), 2180; https://doi.org/10.3390/nu11092180 - 11 Sep 2019

Cited by 38 | Viewed by 3449

Abstract

We hypothesized that resistin is engaged in the development of leptin central insensitivity/resistance in sheep, which is a unique animal model to explore reversible leptin resistance. Thirty Polish Longwool ewes, which were ovariectomized with estrogen replacement, were used. Treatments consisted of the intravenous injection of control (saline) or recombinant bovine resistin (rbresistin): control (Control; n = 10), a low dose of rbresistin (R1; 1.0 μg/kg body weight (BW); n = 10), and a high dose of rbresistin (R2; 10.0 μg/kg BW; n = 10). The studies were performed during short-day (SD) and long-day (LD) photoperiods. Leptin and resistin concentrations were determined. Expression levels of a suppressor of cytokine signaling (SOCS)-3 and the long form of the leptin receptor (LeptRb) were determined in selected brain regions, including in the anterior pituitary (AP), hypothalamic arcuate nucleus (ARC), preoptic area (POA), and ventro- and dorsomedial nuclei (VMH/DMH). The results indicate that resistin induced a consistent decrease in LeptRb (except in POA) and an increase in SOCS-3 expression during the LD photoperiod in all selected brain regions. In conclusion, the results demonstrate that the action of resistin appears to be strongly associated with photoperiod-driven changes in the leptin signaling pathway, which may underlie the phenomenon of central leptin resistance. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

11 pages, 456 KiB

Open AccessArticle

Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass

by Xabier Unamuno, Maitane Izaguirre, Javier Gómez-Ambrosi, Amaia Rodríguez, Beatriz Ramírez, Sara Becerril, Víctor Valentí, Rafael Moncada, Camilo Silva, Javier Salvador, Piero Portincasa, Gema Frühbeck and Victoria Catalán

Nutrients 2019, 11(9), 2069; https://doi.org/10.3390/nu11092069 - 3 Sep 2019

Cited by 29 | Viewed by 3915

Abstract

Bariatric surgery remains the most effective option for achieving important and sustained weight loss. We explored the effects of Roux-en-Y gastric bypass (RYGB) on the circulating levels of adiponectin, leptin, and the adiponectin/leptin (Adpn/Lep) ratio in patients with obesity and type 2 diabetes (T2D). Twenty-five T2D volunteers undergoing RYGB were included in the study, and further subclassified as patients that responded or not to RYBG, regarding remission of T2D. Anthropometric and biochemical variables were evaluated before and after RYGB. Obese patients with T2D exhibited an increase (p < 0.0001) in the Adpn/Lep ratio after RYGB. Changes in the Adpn/Lep ratio correlated better with changes in anthropometric data (p < 0.001) than with the variations of adiponectin or leptin alone. Multiple regression analysis revealed that the change in the Adpn/Lep ratio in patients with T2D was an independent predictor of the changes in body mass index (p < 0.001) and body fat percentage (p = 0.022). However, the Adpn/Lep ratio did not differ between individuals with or without T2D remission after RYGB. In summary, the current study demonstrated that after weight and body fat loss following RYGB, the Adpn/Lep ratio increased in patients with obesity and T2D. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Graphical abstract

11 pages, 1010 KiB

Open AccessArticle

Leptin in Human Milk and Child Body Mass Index: Results of the Ulm Birth Cohort Studies

by Chad A. Logan, Linda P. Siziba, Wolfgang Koenig, Prudence Carr, Hermann Brenner, Dietrich Rothenbacher and Jon Genuneit

Nutrients 2019, 11(8), 1883; https://doi.org/10.3390/nu11081883 - 13 Aug 2019

Cited by 15 | Viewed by 3239

Abstract

The objective of the study was to investigate the potential association of human milk leptin concentrations with child body mass index (BMI) and BMI trajectory patterns up to two years of age among children in the Ulm SPATZ Health Study. Leptin concentration was measured in skimmed human milk by ELISA (R&D System). Child BMI was determined at two to three days, three to four weeks, four to five months, one year, and two years of age. In SPATZ, leptin concentration at six weeks was inversely associated with child BMI at four to five weeks [beta –0.13, 95%CI –0.21;–0.05)] and at three to four months –0.12 –0.21;–0.03)]. Among infants of average BMI shortly after delivery, six week leptin was positively associated with greater increase in BMI from four to five weeks up to two years of age [0.16 (0.04;0.27)]. No associations were observed for six month leptin. Direction of association was the same in the Ulm Birth Cohort Study (UBCS), but statistically insignificant as the point estimate included the null effect value. Our results from SPATZ suggest human milk leptin may play a role in early infant growth. However, it is plausible that the lack of associations in UBCS suggest that these differences of human milk leptin composition between populations could have an impact in infant growth and development in a given population. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

13 pages, 564 KiB

Open AccessArticle

Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation

by Gema Frühbeck, Victoria Catalán, Amaia Rodríguez, Beatriz Ramírez, Sara Becerril, Javier Salvador, Inmaculada Colina and Javier Gómez-Ambrosi

Nutrients 2019, 11(2), 454; https://doi.org/10.3390/nu11020454 - 22 Feb 2019

Cited by 167 | Viewed by 7578

Abstract

Obesity favors the development of cardiometabolic alterations such as type 2 diabetes (T2D) and the metabolic syndrome (MS). Obesity and the MS are distinguished by an increase in circulating leptin concentrations, in parallel to a drop in the levels of adiponectin. Consequently, the Adpn/Lep ratio has been suggested as a maker of dysfunctional adipose tissue. We aimed to investigate in humans (n = 292) the reliability of the Adpn/Lep ratio as a biomarker of adipose tissue dysfunction. We considered that an Adpn/Lep ratio of ≥1.0 can be considered normal, a ratio of ≥0.5 <1.0 suggests moderate-medium increased risk, and a ratio of <0.5 indicates a severe increase in cardiometabolic risk. Using these cut-offs, 5%, 54% and 48% of the lean, normoglycemic and without-MS subjects, respectively, fall within the group with an Adpn/Lep ratio below 0.5; while 89%, 86% and 90% of the obese, with T2D and with MS patients fall within the same group (p < 0.001). A significant negative correlation (r = −0.21, p = 0.005) between the Adpn/Lep ratio and serum amyloid A (SAA) concentrations, a marker of adipose tissue dysfunction, was found. We concluded that the Adpn/Lep ratio is a good indicator of a dysfunctional adipose tissue that may be a useful estimator of obesity- and MS-associated cardiometabolic risk, allowing the identification of a higher number of subjects at risk. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

Review

Jump to: Research

34 pages, 1511 KiB

Open AccessReview

Incendiary Leptin

by Patricia Seoane-Collazo, Noelia Martínez-Sánchez, Edward Milbank and Cristina Contreras

Nutrients 2020, 12(2), 472; https://doi.org/10.3390/nu12020472 - 13 Feb 2020

Cited by 42 | Viewed by 10629

Abstract

Leptin is a hormone released by adipose tissue that plays a key role in the control of energy homeostasis through its binding to leptin receptors (LepR), mainly expressed in the hypothalamus. Most scientific evidence points to leptin’s satiating effect being due to its dual capacity to promote the expression of anorexigenic neuropeptides and to reduce orexigenic expression in the hypothalamus. However, it has also been demonstrated that leptin can stimulate (i) thermogenesis in brown adipose tissue (BAT) and (ii) the browning of white adipose tissue (WAT). Since the demonstration of the importance of BAT in humans 10 years ago, its study has aroused great interest, mainly in the improvement of obesity-associated metabolic disorders through the induction of thermogenesis. Consequently, several strategies targeting BAT activation (mainly in rodent models) have demonstrated great potential to improve hyperlipidemias, hepatic steatosis, insulin resistance and weight gain, leading to an overall healthier metabolic profile. Here, we review the potential therapeutic ability of leptin to correct obesity and other metabolic disorders, not only through its satiating effect, but by also utilizing its thermogenic properties. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

11 pages, 937 KiB

Open AccessReview

Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?

by Andrea G. Izquierdo, Ana B. Crujeiras, Felipe F. Casanueva and Marcos C. Carreira

Nutrients 2019, 11(11), 2704; https://doi.org/10.3390/nu11112704 - 8 Nov 2019

Cited by 326 | Viewed by 29271

Abstract

Leptin, a hormone that is capable of effectively reducing food intake and body weight, was initially considered for use in the treatment of obesity. However, obese subjects have since been found to have high levels of circulating leptin and to be insensitive to the exogenous administration of leptin. The inability of leptin to exert its anorexigenic effects in obese individuals, and therefore, the lack of clinical utility of leptin in obesity, is defined as leptin resistance. This phenomenon has not yet been adequately characterized. Elucidation of the molecular mechanisms underlying leptin resistance is of vital importance for the application of leptin as an effective treatment for obesity. Leptin must cross the blood–brain barrier (BBB) to reach the hypothalamus and exert its anorexigenic functions. The mechanisms involved in leptin transportation across the blood–brain barrier continue to be unclear, thereby preventing the clinical application of leptin in the treatment of obesity. In recent years, new strategies have been developed to recover the response to leptin in obesity. We have summarized these strategies in this review. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

16 pages, 592 KiB

Open AccessReview

Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk

by Manuel F. Landecho, Carlota Tuero, Víctor Valentí, Idoia Bilbao, Magdalena de la Higuera and Gema Frühbeck

Nutrients 2019, 11(11), 2664; https://doi.org/10.3390/nu11112664 - 5 Nov 2019

Cited by 203 | Viewed by 13323

Abstract

Obesity, which is a worldwide epidemic, confers increased risk for multiple serious conditions including type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular diseases. Adipose tissue is considered one of the largest endocrine organs in the body as well as an active tissue for cellular reactions and metabolic homeostasis rather than an inert tissue only for energy storage. The functional pleiotropism of adipose tissue relies on its ability to synthesize and release a large number of hormones, cytokines, extracellular matrix proteins, and growth and vasoactive factors, which are collectively called adipokines known to influence a variety of physiological and pathophysiological processes. In the obese state, excessive visceral fat accumulation causes adipose tissue dysfunctionality that strongly contributes to the onset of obesity-related comorbidities. The mechanisms underlying adipose tissue dysfunction include adipocyte hypertrophy and hyperplasia, increased inflammation, impaired extracellular matrix remodeling, and fibrosis together with an altered secretion of adipokines. This review describes the relevance of specific adipokines in the obesity-associated cardiovascular disease. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

28 pages, 1739 KiB

Open AccessReview

Functional Relationship between Leptin and Nitric Oxide in Metabolism

by Sara Becerril, Amaia Rodríguez, Victoria Catalán, Beatriz Ramírez, Xabier Unamuno, Piero Portincasa, Javier Gómez-Ambrosi and Gema Frühbeck

Nutrients 2019, 11(9), 2129; https://doi.org/10.3390/nu11092129 - 6 Sep 2019

Cited by 46 | Viewed by 7883

Abstract

Leptin, the product of the ob gene, was originally described as a satiety factor, playing a crucial role in the control of body weight. Nevertheless, the wide distribution of leptin receptors in peripheral tissues supports that leptin exerts pleiotropic biological effects, consisting of the modulation of numerous processes including thermogenesis, reproduction, angiogenesis, hematopoiesis, osteogenesis, neuroendocrine, and immune functions as well as arterial pressure control. Nitric oxide (NO) is a free radical synthesized from L-arginine by the action of the NO synthase (NOS) enzyme. Three NOS isoforms have been identified: the neuronal NOS (nNOS) and endothelial NOS (eNOS) constitutive isoforms, and the inducible NOS (iNOS). NO mediates multiple biological effects in a variety of physiological systems such as energy balance, blood pressure, reproduction, immune response, or reproduction. Leptin and NO on their own participate in multiple common physiological processes, with a functional relationship between both factors having been identified. The present review describes the functional relationship between leptin and NO in different physiological processes. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Figure 1

23 pages, 1029 KiB

Open AccessReview

Molecular Insight into the Interaction between Epigenetics and Leptin in Metabolic Disorders

by Adam Wróblewski, Justyna Strycharz, Ewa Świderska, Karolina Drewniak, Józef Drzewoski, Janusz Szemraj, Jacek Kasznicki and Agnieszka Śliwińska

Nutrients 2019, 11(8), 1872; https://doi.org/10.3390/nu11081872 - 12 Aug 2019

Cited by 38 | Viewed by 5399

Abstract

Nowadays, it is well-known that the deregulation of epigenetic machinery is a common biological event leading to the development and progression of metabolic disorders. Moreover, the expression level and actions of leptin, a vast adipocytokine regulating energy metabolism, appear to be strongly associated with epigenetics. Therefore, the aim of this review was to summarize the current knowledge of the epigenetic regulation of leptin as well as the leptin-induced epigenetic modifications in metabolic disorders and associated phenomena. The collected data indicated that the deregulation of leptin expression and secretion that occurs during the course of metabolic diseases is underlain by a variation in the level of promoter methylation, the occurrence of histone modifications, along with miRNA interference. Furthermore, leptin was proven to epigenetically regulate several miRNAs and affect the activity of the histone deacetylases. These epigenetic modifications were observed in obesity, gestational diabetes, metabolic syndrome and concerned various molecular processes like glucose metabolism, insulin sensitivity, liver fibrosis, obesity-related carcinogenesis, adipogenesis or fetal/early postnatal programming. Moreover, the circulating miRNA profiles were associated with the plasma leptin level in metabolic syndrome, and miRNAs were found to be involved in hypothalamic leptin sensitivity. In summary, the evidence suggests that leptin is both a target and a mediator of epigenetic changes that develop in numerous tissues during metabolic disorders. Full article

(This article belongs to the Special Issue Leptin)

► Show Figures

Journal Menu

Journal Browser

Leptin

Share This Special Issue

Special Issue Editors

Special Issue Information

Keywords

Benefits of Publishing in a Special Issue

Published Papers (10 papers)

Research

Review

Further Information

Guidelines

MDPI Initiatives

Follow MDPI